H Stemberger

415 total citations
44 papers, 327 citations indexed

About

H Stemberger is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, H Stemberger has authored 44 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Infectious Diseases and 10 papers in Epidemiology. Recurrent topics in H Stemberger's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Biochemical and Molecular Research (7 papers) and Drug-Induced Adverse Reactions (6 papers). H Stemberger is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Biochemical and Molecular Research (7 papers) and Drug-Induced Adverse Reactions (6 papers). H Stemberger collaborates with scholars based in Austria, Germany and Switzerland. H Stemberger's co-authors include G Wiedermann, Herwig Kollaritsch, Pamela Rendi‐Wagner, Michaël Hofer, Michael Kundi, Heidemarie Holzmann, Otto Scheiner, Hans Lassmann, K. Kitz and Henryk M. Wı́sniewski and has published in prestigious journals such as Vaccine, Journal of Immunological Methods and Journal of the Neurological Sciences.

In The Last Decade

H Stemberger

39 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Stemberger Austria 10 127 91 73 70 54 44 327
M Yebra Spain 12 231 1.8× 79 0.9× 38 0.5× 19 0.3× 49 0.9× 34 534
A. I. O. Williams Nigeria 12 75 0.6× 36 0.4× 160 2.2× 22 0.3× 26 0.5× 30 376
Albert P. McKee United States 10 241 1.9× 83 0.9× 38 0.5× 83 1.2× 50 0.9× 32 393
David A. Cooper Australia 9 152 1.2× 320 3.5× 71 1.0× 43 0.6× 36 0.7× 11 491
F. A. Murphy United States 6 129 1.0× 73 0.8× 102 1.4× 14 0.2× 29 0.5× 8 312
I Srivastava United States 9 67 0.5× 84 0.9× 134 1.8× 10 0.1× 100 1.9× 14 397
Mohamed Shehata Egypt 11 129 1.0× 45 0.5× 54 0.7× 114 1.6× 20 0.4× 28 485
Rutherford B. Polhill United States 7 128 1.0× 67 0.7× 150 2.1× 7 0.1× 35 0.6× 11 365
Elizabeth R. Jenny-Avital United States 11 401 3.2× 335 3.7× 52 0.7× 59 0.8× 59 1.1× 18 528
Niamh M. Keane Australia 14 201 1.6× 107 1.2× 228 3.1× 62 0.9× 75 1.4× 17 561

Countries citing papers authored by H Stemberger

Since Specialization
Citations

This map shows the geographic impact of H Stemberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Stemberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Stemberger more than expected).

Fields of papers citing papers by H Stemberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Stemberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Stemberger. The network helps show where H Stemberger may publish in the future.

Co-authorship network of co-authors of H Stemberger

This figure shows the co-authorship network connecting the top 25 collaborators of H Stemberger. A scholar is included among the top collaborators of H Stemberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Stemberger. H Stemberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rendi‐Wagner, Pamela, Michael Kundi, H Stemberger, et al.. (2001). Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine. 19(15-16). 2055–2060. 88 indexed citations
2.
Wiedermann, Ursula, et al.. (1991). Intestinal Worm Burden and Serum Cholesterol or Lipid Concentration in a Shipibo Population (Peru). Zentralblatt für Bakteriologie. 275(2). 279–286. 13 indexed citations
3.
Kollaritsch, Herwig, et al.. (1990). [Correlation of inguinal hernia and agglutinating sperm antibodies].. PubMed. 115(6). 369–77. 4 indexed citations
4.
Kremsner, Peter G., et al.. (1990). Restoration of Defective Cytokine Activity within Lepromatous Leprosy Lesions. Zentralblatt für Bakteriologie. 272(4). 458–466. 3 indexed citations
5.
Kollaritsch, Herwig, H Stemberger, Marina Binder, & G Wiedermann. (1989). Suitability of the Phast® system for discrimination of Entamoeba isolates by isoenzyme isoelectrofocusing. Transactions of the Royal Society of Tropical Medicine and Hygiene. 83(2). 211–212. 6 indexed citations
6.
Kollaritsch, Herwig, J. Graf, H Stemberger, et al.. (1989). Interaction of Different Strains of Entamoeba histolytica with Target Cells: Characterization of Electrophysiological and Morphological Features. Immunobiology. 179(2-3). 190–201. 6 indexed citations
7.
Kollaritsch, Herwig, et al.. (1988). Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef®): results of a double blind field trial versus chloroquine in Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 82(4). 524–529. 14 indexed citations
8.
Lassmann, Hans, Gerda Suchanek, K. Kitz, et al.. (1984). Antibodies in the pathogenesis of demyelination in chronic relapsing EAE (cr-EAE).. PubMed. 146. 165–70. 12 indexed citations
9.
Stemberger, H, et al.. (1984). Tolerability of long-term prophylaxis with Fansidar : a randomized double-blind study in Nigeria. PubMed. 41(4). 391–9. 10 indexed citations
10.
Stemberger, H, et al.. (1983). [Entamoeba histolytica: I. Mechanism of cytotoxic activity].. PubMed. 34(4). 248–52. 1 indexed citations
11.
Lassmann, Hans, H Stemberger, K. Kitz, & Henryk M. Wı́sniewski. (1983). In vivo demyelinating activity of sera from animals with chronic experimental allergic encephalomyelitis. Journal of the Neurological Sciences. 59(1). 123–137. 26 indexed citations
12.
Scheiner, Otto, et al.. (1980). Adenine and hypoxanthine metabolism in phythohemagglutinin-stimulated and unstimulated human lymphocytes. Annals of Hematology. 40(2). 137–145. 3 indexed citations
13.
Müller, Mathias, et al.. (1979). Purine metabolism in human lymphocytes. Annals of Hematology. 38(6). 447–455. 6 indexed citations
14.
Ambrosch, F, H Stemberger, G Wiedermann, Gerold Stanek, & Dragana J. Jovanović. (1978). Determination of meningococcal antibodies by microassay.. PubMed. 56(5). 787–90. 4 indexed citations
15.
Wiedermann, G, Marina Müller, O Förster, & H Stemberger. (1975). Influence of Surface Hapten Density of Sheep Red Blood Cells on the Hemolytic or Blocking Activity of IgG Antibodies. International Archives of Allergy and Immunology. 49(6). 843–854. 4 indexed citations
16.
Wiedermann, G, Helmut Denk, H Stemberger, R. Eckerstorfer, & G Tappeiner. (1975). Influence of the antigenicity of target cells on the antibody-mediated cytotoxicity of nonsensitized lymphocytes. Cellular Immunology. 17(2). 440–446. 9 indexed citations
17.
Kux, M., F Piza, H Stemberger, Otto Wagner, & G Wiedermann. (1974). Immediate Complement Consumption in Human Renal Allografts. European Surgical Research. 6(1). 5–10. 2 indexed citations
18.
Müller, Mathias & H Stemberger. (1974). Immunological Studies of Hypoxanthine-Guanine Phosphoribosyltransferase in Lesch-Nyhan Syndrome. Advances in experimental medicine and biology. 41. 187–194. 2 indexed citations
19.
Stemberger, H, et al.. (1974). [Biochemical and immunological studies of hypoxanthine-guanine phosphoribosyltransferase in erythrocytes of Lesch-Nyhan patients (author's transl)].. PubMed. 86(5). 127–31. 2 indexed citations
20.
Stemberger, H, et al.. (1973). Der Nachweis von Enzymprotein der Hypoxanthin-Guanin-Phosphoribosyltransferase bei Lesch-Nyhan-Syndrom. Journal of Molecular Medicine. 51(2). 88–89. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Yebra Breakdown of academic impact, for papers by A. I. O. Williams Breakdown of academic impact, for papers by Albert P. McKee Breakdown of academic impact, for papers by David A. Cooper Breakdown of academic impact, for papers by F. A. Murphy Breakdown of academic impact, for papers by I Srivastava Breakdown of academic impact, for papers by Mohamed Shehata Breakdown of academic impact, for papers by Rutherford B. Polhill Breakdown of academic impact, for papers by Elizabeth R. Jenny-Avital Breakdown of academic impact, for papers by Niamh M. Keane
Rankless by CCL
2026